CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Income Statement [Abstract]
Revenue
Operating expenses:
General and administrative (including stock-based compensation)	959,403	666,255
Depreciation	285	461
Research and development (including stock-based compensation)	6,374	8,299
Total operating expenses	966,062	675,015
Loss from operations	(966,062)	(675,015)
Other (income) expense:
Interest income	(18)	(395)
Interest expense	205,592	70,927
Total other expense	205,574	70,532
Net (loss)	(1,171,636)	(745,547)
Net (loss) attributable to the noncontrolling interest
Net (loss) applicable to Bion's common stockholders	$ (1,171,636)	$ (745,547)
Net (loss) applicable to Bion's common stockholders
Net (loss) applicable to Bion's common stockholders per basic common share	$ (0.02)	$ (0.02)
Net (loss) applicable to Bion's common stockholders per diluted common share	$ (0.02)	$ (0.02)
Weighted-average number of common shares outstanding:
Weighted-average number of common shares outstanding, Basic	56,530,665	48,617,675
Weighted-average number of common shares outstanding Diluted	56,530,665	48,617,675